公开(公告)号：US08564868B2

公开(公告)日：2013-10-22

申请号：US13051016

申请日：2011-03-18

申请人： Shinya Kusuda ,  Shogo Mori

发明人： Shinya Kusuda ,  Shogo Mori

IPC分类号： G02B26/08

CPC分类号： G02B26/121 ,  B41J2/471 ,  B41J29/02 ,  H04N1/1135 ,  H04N1/12 ,  H04N2201/0082

摘要： A light scanning apparatus includes: a light source configured to emit a light beam; a deflector configured to deflect and scan the light beam from the light source in a main scanning direction; a control substrate that is configured to control driving of the light source and includes a first connection part to which the light source is connected and a second connection part for connecting an external terminal; and a housing that supports the control substrate. The first connection part is arranged within the housing and the second connection part is exposed and arranged at the outside of the housing.

摘要翻译： 光扫描装置包括：被配置为发射光束的光源; 偏转器，被构造成在主扫描方向上偏转和扫描来自光源的光束; 控制基板，被配置为控制所述光源的驱动，并且包括连接有所述光源的第一连接部和用于连接外部端子的第二连接部; 以及支撑控制基板的壳体。 第一连接部分布置在壳体内，第二连接部分暴露并布置在壳体的外部。

公开(公告)号：US20130086907A1

公开(公告)日：2013-04-11

申请号：US13639621

申请日：2010-10-20

申请人： Yoshinori Oba ,  Tsutomu Oishi ,  Nozomi Tanaka ,  Shinya Kusuda

发明人： Yoshinori Oba ,  Tsutomu Oishi ,  Nozomi Tanaka ,  Shinya Kusuda

IPC分类号： F02K1/48 ,  F02C7/00

CPC分类号： F02K1/48 ,  F02C7/00 ,  F02C7/045 ,  F02K1/08 ,  F02K1/386 ,  F02K1/46 ,  F05D2240/127 ,  F05D2250/61 ,  F05D2260/14 ,  Y02T50/671

摘要： The present invention relates to a jet engine including protrusions (1) for preventing the increase of the velocity gradient of a fluid in a mixed layer of a jet flow and an external air flow by bending the mixed layer, when viewed from the side of a jet flow injected.

摘要翻译： 喷气发动机技术领域本发明涉及一种喷气发动机，其包括突起（1），用于通过弯曲混合层来防止喷射流和外部空气流的混合层中的流体的速度梯度的增加，当从 注射射流。

公开(公告)号：US20120228054A1

公开(公告)日：2012-09-13

申请号：US13504200

申请日：2010-10-27

申请人： Nozomi Tanaka ,  Shinya Kusuda ,  Tsutomu Oishi ,  Yoshinori Oba

发明人： Nozomi Tanaka ,  Shinya Kusuda ,  Tsutomu Oishi ,  Yoshinori Oba

IPC分类号： F01N13/10

CPC分类号： F02K1/34 ,  F02C6/08 ,  F02K1/38 ,  F02K1/44 ,  F02K1/46 ,  F02K1/52 ,  F05D2220/323 ,  F05D2260/96

摘要： A noise reduction system with a chamber includes a chamber (17) which is provided at a portion of a supply path connecting a flow path in an upstream side of a combustor in a jet engine to a plurality of microjet nozzles which is provided at an exhaust side peripheral edge of a main nozzle of the jet engine, wherein the supply path is configured to supply part of compressed air from the flow path into the chamber (17), and the chamber (17) is configured to inject the compressed air through the plurality of the microjet nozzles (63) to a jet flow.

摘要翻译： 具有腔室的降噪系统包括：室（17），其设置在将喷气发动机中的燃烧器的上游侧的流路连接到设置在排气口处的多个微喷嘴的供给路径的一部分 其中所述供应路径被配置为将来自所述流动路径的压缩空气的一部分供应到所述室（17）中，并且所述室（17）被配置为将所述压缩空气喷射通过所述喷射发动机的主喷嘴 多个微喷嘴（63）到喷射流。

公开(公告)号：US20110235144A1

公开(公告)日：2011-09-29

申请号：US13069794

申请日：2011-03-23

申请人： Shinya KUSUDA ,  Shogo MORI

发明人： Shinya KUSUDA ,  Shogo MORI

IPC分类号： G02B26/12

CPC分类号： B41J2/471 ,  B41J29/02

摘要： A light scanning device includes: a light source configured to emit a light beam; a deflector configured to deflect and scan the light beam from the light source in a main scanning direction; a driving source that drives the deflector; and a housing including a support wall to which the driving source is fixed. The support wall has a first surface, a second surface to which the driving source is fixed and that is deviated with respect to the first surface in a direction perpendicular to the first surface, and a third surface that connects the first surface and the second surface and is inclined to form obtuse angles relative to the first surface and the second surface.

摘要翻译： 光扫描装置包括：被配置为发射光束的光源; 偏转器，被构造成在主扫描方向上偏转和扫描来自光源的光束; 驱动偏转器的驱动源; 以及壳体，其包括固定有驱动源的支撑壁。 所述支撑壁具有第一表面，所述驱动源固定到所述第一表面的第二表面，并且所述第二表面在垂直于所述第一表面的方向上相对于所述第一表面偏离;第三表面，其将所述第一表面和所述第二表面 并且倾斜成相对于第一表面和第二表面形成钝角。

公开(公告)号：US20110235142A1

公开(公告)日：2011-09-29

申请号：US13051016

申请日：2011-03-18

申请人： Shinya KUSUDA ,  Shogo MORI

发明人： Shinya KUSUDA ,  Shogo MORI

IPC分类号： G02B26/10

CPC分类号： G02B26/121 ,  B41J2/471 ,  B41J29/02 ,  H04N1/1135 ,  H04N1/12 ,  H04N2201/0082

摘要： A light scanning apparatus includes: a light source configured to emit a light beam; a deflector configured to deflect and scan the light beam from the light source in a main scanning direction; a control substrate that is configured to control driving of the light source and includes a first connection part to which the light source is connected and a second connection part for connecting an external terminal; and a housing that supports the control substrate. The first connection part is arranged within the housing and the second connection part is exposed and arranged at the outside of the housing.

摘要翻译： 光扫描装置包括：被配置为发射光束的光源; 偏转器，被构造成在主扫描方向上偏转和扫描来自光源的光束; 控制基板，被配置为控制所述光源的驱动，并且包括连接有所述光源的第一连接部和用于连接外部端子的第二连接部; 以及支撑控制基板的壳体。 第一连接部分布置在壳体内，第二连接部分暴露并布置在壳体的外部。

公开(公告)号：US08003642B2

公开(公告)日：2011-08-23

申请号：US12282464

申请日：2007-03-09

申请人： Shinya Kusuda ,  Toshihiko Nishiyama ,  Kazuya Hashimura ,  Junya Ueda ,  Shiro Shibayama

发明人： Shinya Kusuda ,  Toshihiko Nishiyama ,  Kazuya Hashimura ,  Junya Ueda ,  Shiro Shibayama

IPC分类号： A61K31/5377 ,  A61K31/4545 ,  C07D413/14 ,  C07D401/14

CPC分类号： C07D401/12 ,  C07D401/14 ,  C07D417/14 ,  C07D419/14

摘要： The compound represented by formula (I), a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof specifically binds CCR5, so it is useful for preventing and/or treating CCR5-related diseases, for example, various inflammatory diseases (asthma, nephritis, nephropathy, hepatitis, arthritis, rheumatoid arthritis, rhinitis, conjunctivitis, ulcerative colitis, etc.), immunological diseases (autoimmune diseases, rejection in organ transplantation, immunosuppression, psoriasis, multiple sclerosis, etc.), infectious diseases (infection with human immunodeficiency virus, acquired immunodeficiency syndrome, etc.), allergic diseases (atopic dermatitis, urticaria, allergic bronchopulmonary aspergillosis, allergic eosinophilic gastroenteritis, etc.), ischemic reperfusion injury, acute respiratory distress syndrome, shock accompanying bacterial infection diabetes cancer metastasis and so on Wherein all symbols in formula are as defined in the specification.

摘要翻译： 由式（I）表示的化合物，其盐，其N-氧化物，其溶剂合物或其前药特异性结合CCR5，因此其可用于预防和/或治疗CCR5相关疾病，例如各种 炎性疾病（哮喘，肾炎，肾病，肝炎，关节炎，类风湿性关节炎，鼻炎，结膜炎，溃疡性结肠炎等），免疫疾病（器官移植中的自身免疫性疾病，排斥反应，免疫抑制，牛皮癣，多发性硬化症等），感染性 疾病（人体免疫缺陷病毒感染，获得性免疫缺陷综合征等），过敏性疾病（特应性皮炎，荨麻疹，过敏性支气管肺曲霉病，过敏嗜酸性胃肠炎等），缺血再灌注损伤，急性呼吸窘迫综合征，伴随细菌感染糖尿病的休克 癌症转移等等，其中公式中的所有符号如说明书中所定义。

公开(公告)号：US07560475B2

公开(公告)日：2009-07-14

申请号：US10572937

申请日：2004-09-21

申请人： Shinya Kusuda ,  Yoshisuke Nakayama ,  Hisao Tajima ,  Takahiko Sakamoto

发明人： Shinya Kusuda ,  Yoshisuke Nakayama ,  Hisao Tajima ,  Takahiko Sakamoto

IPC分类号： A01N31/425 ,  A01N43/50 ,  A01N43/76 ,  A01N43/78 ,  A61K31/42 ,  A61K31/415 ,  C07D233/54 ,  C07D263/30 ,  C07D277/22 ,  C07D413/00

CPC分类号： C07D413/10 ,  A61K31/421 ,  A61K31/422 ,  A61K31/426 ,  A61K31/4439 ,  A61K31/454

摘要： The present invention relates to the compound represented by formula (I) (wherein R1 and R2 is hydrogen atom, C1-8 alkyl etc.; R3 is C1-8 alkyl which may be substituted with 1 to 3 halogen atom(s), phenyl; R4 is hydrogen atom etc.; R5 and R6 is hydrogen atom, C1-8 alkyl etc.; X is sulfur atom or oxygen atom etc.; ringA is cyclic group which may have a substituent(s).), or a salt thereof. Toxicity of the compound represented by formula (I) is very low, and it is safe enough to use as a pharmaceutical agent and since it has PPAR δ agonistic activity, it is useful as preventive and/or therapeutic agent for glucose•lipid metabolic disorder, hypertension, circulatory diseases etc.

摘要翻译： 本发明涉及由式（I）表示的化合物（其中R 1和R 2是氢原子，C 1-8烷基等; R 3是可被1至3个卤素原子取代的C 1-8烷基，苯基 ; R4为氢原子等; R5和R6为氢原子，C1-8烷基等; X为硫原子或氧原子等;环A为可具有取代基的环状基团）或盐 其中。 由式（I）表示的化合物的毒性非常低，并且作为药物使用是安全的，并且由于其具有PPARδ激动活性，因此它可用作葡萄糖脂代谢紊乱的预防和/或治疗剂 ，高血压，循环系统疾病等

公开(公告)号：US09201238B2

公开(公告)日：2015-12-01

申请号：US14099556

申请日：2013-12-06

申请人： Shinya Kusuda

发明人： Shinya Kusuda

IPC分类号： G02B26/10 ,  G02B26/12

CPC分类号： G02B26/10 ,  G02B26/125

摘要： In an optical scanning device, a lower frame includes a first wall contacting an optical element, a second wall connected to a second-wall connecting portion of the first wall, a third wall connected to a third-wall connecting portion of the first wall, and a biasing member having a first end contacting the optical element and a second end supported by a scanner frame to press the optical element against the first wall. The second wall extends in a traverse direction angled with respect to a direction in which the first wall extends. The third wall extends in a direction facing away from an optical element side of the first wall on which the optical element is located. The optical element is in contact with at least one position of the first wall which position is between the second-wall connecting position and the third-wall connecting position.

摘要翻译： 在光学扫描装置中，下框架包括接触光学元件的第一壁，连接到第一壁的第二壁连接部分的第二壁，连接到第一壁的第三壁连接部分的第三壁， 以及偏置构件，其具有接触光学元件的第一端和由扫描器框架支撑的第二端，以将光学元件压靠在第一壁上。 第二壁在相对于第一壁延伸的方向成角度的横向方向上延伸。 第三壁沿着远离光学元件所在的第一壁的光学元件侧的方向延伸。 光学元件与位于第二壁连接位置和第三壁连接位置之间的第一壁的至少一个位置接触。

公开(公告)号：US20090131403A1

公开(公告)日：2009-05-21

申请号：US12282464

申请日：2007-03-09

申请人： Shinya Kusuda ,  Toshihiko Nishiyama ,  Kazuya Hashimura ,  Junya Ueda ,  Shiro Shibayama

发明人： Shinya Kusuda ,  Toshihiko Nishiyama ,  Kazuya Hashimura ,  Junya Ueda ,  Shiro Shibayama

IPC分类号： A61K31/554 ,  C07D401/14 ,  A61K31/497 ,  A61K31/4545 ,  C07D413/14 ,  A61K31/5377 ,  C07D419/14

CPC分类号： C07D401/12 ,  C07D401/14 ,  C07D417/14 ,  C07D419/14

摘要： The compound represented by formula (I), a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof specifically binds CCR5, so it is useful for preventing and/or treating CCR5-related diseases, for example, various inflammatory diseases (asthma, nephritis, nephropathy, hepatitis, arthritis, rheumatoid arthritis, rhinitis, conjunctivitis, ulcerative colitis, etc.), immunological diseases (autoimmune diseases, rejection in organ transplantation, immunosuppression, psoriasis, multiple sclerosis, etc.), infectious diseases (infection with human immunodeficiency virus, acquired immunodeficiency syndrome, etc.), allergic diseases (atopic dermatitis, urticaria, allergic bronchopulmonary aspergillosis, allergic eosinophilic gastroenteritis, etc.), ischemic reperfusion injury, acute respiratory distress syndrome, shock accompanying bacterial infection diabetes cancer metastasis and so on. Wherein all symbols in formula are as defined in the specification

摘要翻译： 由式（I）表示的化合物，其盐，其N-氧化物，其溶剂合物或其前药特异性结合CCR5，因此其可用于预防和/或治疗CCR5相关疾病，例如各种 炎性疾病（哮喘，肾炎，肾病，肝炎，关节炎，类风湿性关节炎，鼻炎，结膜炎，溃疡性结肠炎等），免疫疾病（器官移植中的自身免疫性疾病，排斥反应，免疫抑制，牛皮癣，多发性硬化症等），感染性 疾病（人体免疫缺陷病毒感染，获得性免疫缺陷综合征等），过敏性疾病（特应性皮炎，荨麻疹，过敏性支气管肺曲霉病，过敏嗜酸性胃肠炎等），缺血再灌注损伤，急性呼吸窘迫综合征，伴随细菌感染糖尿病的休克 癌转移等。 其中公式中的所有符号如说明书中所定义

公开(公告)号：US20070167490A1

公开(公告)日：2007-07-19

申请号：US10548650

申请日：2004-03-12

申请人： Akiharu Ishida ,  Shinya Kusuda ,  Yoshisuke Nakayama ,  Hisao Tajima ,  Tomoyuki Kido ,  Tetsuya Kitamine

发明人： Akiharu Ishida ,  Shinya Kusuda ,  Yoshisuke Nakayama ,  Hisao Tajima ,  Tomoyuki Kido ,  Tetsuya Kitamine

IPC分类号： A61K31/4439 ,  A61K31/44 ,  A61K31/381 ,  A61K31/415

CPC分类号： C07D213/30 ,  C07C251/54 ,  C07D207/20 ,  C07D209/08 ,  C07D211/70 ,  C07D213/50 ,  C07D213/53 ,  C07D213/55 ,  C07D231/12 ,  C07D233/54 ,  C07D249/08 ,  C07D257/04 ,  C07D277/04 ,  C07D295/13 ,  C07D307/52 ,  C07D319/08 ,  C07D333/22 ,  C07D403/12 ,  C07D407/10 ,  C07D407/12 ,  C07D409/04 ,  C07D417/10

摘要： The compound represented by formula (I) (wherein R1 and R2 are cyclic group which may have a substituent(s) and so on; W is a spacer of which main chain has an atom number of 1-6.; X is —O— and so on; ring A is cyclic group which may have a substituent(s); Y is a spacer of which main chain has an atom number of 1-6 and so on; Z is acidic group.) a salt thereof, a solvent thereof or an N-oxide thereof, or a prodrug thereof Since the compounds in the present invention have a regulatory activity for peroxisome proliferator activated receptor, the compounds in the present invention are useful as a preventive and/or therapeutic agent for diseases associating metabolic disorders (e.g., hypercholesterolemia, hyperlipoproteinemia, etc.), hyperlipidemia, atherosclerosis, hypertension, circulatory diseases, overeating, ischemic heart diseases, etc., an HDL cholesterol-elevating agent, an LDL cholesterol and/or a VLDL cholesterol-lowering agent and a drug for relief from risk factors of diabetes or metabolic syndrom.

摘要翻译： 由式（I）表示的化合物（其中R 1和R 2）是可以具有取代基等的环状基团; W是其中的间隔基 主链的原子数为1-6; X为-O-等;环A为可具有取代基的环状基团; Y为主链的原子数为1〜 6等等; Z是酸性基团）其盐，其溶剂或其N-氧化物或其前药由于本发明的化合物对过氧化物酶体增殖物激活受体具有调节活性，所以化合物 本发明可用作将代谢紊乱（例如高胆固醇血症，高脂蛋白血症等），高脂血症，动脉粥样硬化，高血压，循环系统疾病，暴饮暴食，缺血性心脏病等相关的疾病的预防和/或治疗剂，HDL胆固醇 - 升高剂，LDL胆固醇和/或VLDL胆固醇降低剂和用于缓解ris的药物 k因素糖尿病或代谢综合征。